Name | Arbor View |
---|---|
Location | 7991 W 71st Ave, Arvada, Colorado |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 120 |
Occupancy Rate | 64.33% |
Medicare ID (CCN) | 065330 |
Legal Business Name | Hackberry Hill Opco Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1194715474 |
Organization Name | SCL HEALTH FRONT RANGE, INC |
Doing Business As | COLORADO LUTHERAN HOME |
Address | 7991 W 71st Ave, Arvada, CO 80004 |
Phone Number | 303-403-3110 |
News Archive
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
Blending the healthcare profession and systems engineering, two professors at The University of Alabama in Huntsville are applying manufacturing efficiency systems to healthcare settings to promote better patient satisfaction.
Researchers have now shown that the best way to lose weight is to lose a lot of it at once contrary to popular belief even among doctors that weight should be lost slowly.
› Verified 8 days ago
NPI Number | 1295207348 |
Organization Name | HACKBERRY HILL OPCO LLC |
Address | 7991 W 71st Ave, Arvada, CO 80004 |
Phone Number | 303-403-3100 |
News Archive
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
Blending the healthcare profession and systems engineering, two professors at The University of Alabama in Huntsville are applying manufacturing efficiency systems to healthcare settings to promote better patient satisfaction.
Researchers have now shown that the best way to lose weight is to lose a lot of it at once contrary to popular belief even among doctors that weight should be lost slowly.
› Verified 8 days ago
NPI Number | 1306368717 |
Organization Name | HACKBERRY HILL OPCO LLC |
Doing Business As | ARBOR VIEW |
Address | 7991 W 71st Ave, Arvada, CO 80004 |
Phone Number | 303-403-3110 |
News Archive
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
Blending the healthcare profession and systems engineering, two professors at The University of Alabama in Huntsville are applying manufacturing efficiency systems to healthcare settings to promote better patient satisfaction.
Researchers have now shown that the best way to lose weight is to lose a lot of it at once contrary to popular belief even among doctors that weight should be lost slowly.
› Verified 8 days ago
NPI Number | 1518710599 |
Organization Name | ARBOR VIEW CARE CENTER LLC |
Address | 7991 W 71st Ave, Arvada, CO 80004 |
Phone Number | 303-403-3100 |
News Archive
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
Blending the healthcare profession and systems engineering, two professors at The University of Alabama in Huntsville are applying manufacturing efficiency systems to healthcare settings to promote better patient satisfaction.
Researchers have now shown that the best way to lose weight is to lose a lot of it at once contrary to popular belief even among doctors that weight should be lost slowly.
› Verified 8 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
Blending the healthcare profession and systems engineering, two professors at The University of Alabama in Huntsville are applying manufacturing efficiency systems to healthcare settings to promote better patient satisfaction.
Researchers have now shown that the best way to lose weight is to lose a lot of it at once contrary to popular belief even among doctors that weight should be lost slowly.
› Verified 8 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 2 |
Total Amount of Fines in Dollars | $38356 |
Number of Payment Denials | 0 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 20.06 | 14.46 |
Percentage of long-stay residents who lose too much weight | 6.45 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 50.74 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.14 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 5.43 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 7.25 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.38 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.59 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 14.08 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 76.4 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 22.4 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 2.52 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 1.34 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.61 | 95.98 |
Percentage of short-stay residents who made improvements in function | 68.62 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 74.44 | 82.93 |
News Archive
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
Blending the healthcare profession and systems engineering, two professors at The University of Alabama in Huntsville are applying manufacturing efficiency systems to healthcare settings to promote better patient satisfaction.
Researchers have now shown that the best way to lose weight is to lose a lot of it at once contrary to popular belief even among doctors that weight should be lost slowly.
› Verified 8 days ago
Arvada Care And Rehabilitation Center Location: 6121 W 60th Ave, Arvada, Colorado 80003 Phone: (303) 420-4550 | |